Skip to content

Keith S Manchester, Director at Roivant Sciences, sold ROIV on Jun 30, 2026

Data as of Oct 16

▼ SELL$437K12,380 shares at $35.28Keith S Manchester DirectorROIV Roivant Sciences Ltd.
Watch ROIV
Traded
Jun 30, 2026
Disclosed
Jun 30, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Keith S Manchester, Director at Roivant Sciences, sold ROIV on Jun 30, 2026TRADEDDISCLOSED
ROIVSimilar stocks (XLV — its sector index fund), rebased to ROIV's price on the disclosure day
ROIV since disclosure
−5.3%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund

Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$7.1Mdisclosed Jun 30 · filed the same day
  2. ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$6.9Mdisclosed Jun 30 · filed 1 day after the trade
  3. ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$20.8Mdisclosed Jun 30 · filed 1 day after the trade
  4. ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$10.2Mdisclosed Jun 30 · filed 4 days after the trade
  5. ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$11.1Mdisclosed Jun 30 · filed 4 days after the trade

See every trade on ROIV →